Revenue Update on Arcadia Biosciences Inc(NASDAQ:RKDA)

Arcadia Biosciences Inc(NASDAQ:RKDA) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Aug 9, 2016. Company reported revenue of $721.00K. Analysts estimated a revenue of $1.90M. Earnings per share were $-0.10. Analysts had estimated an EPS of $-0.07.

Arcadia Biosciences Inc (RKDA) shares turned negative on Wednesdays trading session with the shares closing down -0.07 points or -3.52% at a volume of 16,068. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $2.139. The peak price level was also seen at $2.139 while the days lowest was $1.91. Finally the shares closed at $1.92. The 52-week high of the shares is $6.97 while the 52-week low is $1.1. According to the latest information available, the market cap of the company is $85 M.

Several Insider Transactions has been reported to the SEC. On Aug 8, 2016, Roger Salameh (Chief Operating Officer) sold 100 shares at $2.51 per share price.Also, On Jun 15, 2016, Steven F. Brandwein (Interim Chief Financ. Officer) sold 8,280 shares at $2.49 per share price.On Apr 6, 2016, Vic C. Knauf (Chief Scientific Officer) sold 2,853 shares at $2.98 per share price, according to the Form-4 filing with the securities and exchange commission.

Arcadia Biosciences Inc. is an agricultural biotechnology trait company. The Company has a portfolio of late-stage yield and product quality traits addressing multiple crops that supply the food and feed markets. The Company’s traits are focused on enhancements that increase crop yields by enabling plants to manage environmental and nutrient stresses. The Company has over 50 products in development using its traits and there are 13 in advanced stages of development or on the market. Its crop yield traits are utilized by its commercial partners to develop higher yielding seeds for crops including wheat rice soybean corn and sugarcane as well as for other crops such as cotton canola turf and trees. The Company uses both (genetically modified) GM and non-GM technologies to develop its traits.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Arcadia Biosciences Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Arcadia Biosciences Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.